Viewing nowCrosstin 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
CELTRION PHARMACEUTICALS, Co., Ltd.

MFDS item code 201707535 · Approved 2017.10.20 · Insurance code 693902680
Improvement of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular diseases
This medication is used for patients with various types of hyperlipidemia and dyslipidemia. It is used as an adjunct when dietary control and exercise are insufficient in patients with primary hypercholesterolemia or familial hypercholesterolemia, and in patients with mixed hyperlipidemia. It particularly helps in the treatment of patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia and lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby slowing the progression of atherosclerosis. It is also safely used to control cholesterol levels in pediatric patients aged 10 to 17 years with familial hypercholesterolemia. For middle-aged and older patients at high risk for cardiovascular diseases, it contributes to the reduction of the risk of stroke, myocardial infarction, and revascularization. Thus, this drug is effectively used to improve various forms of dyslipidemia and cardiovascular risk factors.
The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and the patient's response, up to a maximum of 20 milligrams once daily. Elderly patients: No dose adjustment is necessary. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
10 to 17 years of age: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For instance, those allergic to the components of this medication, individuals with severe liver impairment, patients with muscle disorders, and those taking certain medications should not take this drug. Women who are pregnant or breastfeeding, as well as fertile women who are not using appropriate contraceptive methods, should consult a physician before taking this medication and may only take it if it is understood that the risk to the fetus is low. Caution is advised for patients with liver disease or those who consume alcohol excessively, and regular liver function tests should be conducted. Additionally, if symptoms such as muscle pain or muscle weakness occur, the physician should be notified immediately. Patients with various factors that may increase the risk of muscle damage, such as renal impairment, hypothyroidism, a history of hereditary muscle diseases, alcohol abuse, and concomitant use of certain medications, should be monitored more closely. This drug contains lactose, so patients with lactose intolerance should avoid taking it. During treatment with this drug, liver function and muscle condition should be regularly checked, and any unusual symptoms should be reported to healthcare professionals immediately. This drug may interact with other medications; therefore, patients should inform their doctor or pharmacist about any other medications they are taking. Special caution is required when used with certain antiviral medications, immunosuppressants, antibiotics, and lipid-lowering agents. Pregnant or breastfeeding women should not use this medication, and women of childbearing potential should use appropriate contraception. In case of overdose, there is no specific antidote, and immediate medical attention should be sought for appropriate treatment and examination. This drug is not known to significantly affect driving or the operation of machinery; however, caution is advised due to the potential occurrence of dizziness and other symptoms. Lastly, while taking this medication, serious skin reactions, severe liver damage, and muscle-related anomalies may occur; if such symptoms are suspected, the medication should be discontinued immediately, and medical advice should be sought.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, severe muscle weakness, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug rash with eosinophilia, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, decreased appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture and should be kept at room temperature between 1 to 30 degrees Celsius.
Yellow round film-coated tablets
28 tablets (14 tablets/PTP*2), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
CELTRION PHARMACEUTICALS, Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.